J&J, Bayer, Pfizer Announce Substantial Layoffs Amid Industry Challenges

The pharmaceutical industry is experiencing significant layoffs, with major companies like Johnson & Johnson, Bayer, and Pfizer announcing substantial workforce reductions. Johnson & Johnson plans to cut 231 jobs in New Brunswick, New Jersey, as part of efforts to adapt to a rapidly changing environment, influenced by factors such as the expiration of key patents and market dynamics[1][2]. Bayer is also reducing its workforce in Whippany, New Jersey, by 57 positions, continuing its broader strategy to enhance agility and restructure after significant acquisitions[3][1]. Meanwhile, Pfizer is cutting up to 210 manufacturing jobs in Ireland as part of an effort to increase efficiency following earlier U.S. reductions[2].